{"id":598238,"date":"2022-05-02T19:10:02","date_gmt":"2022-05-02T19:10:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=598238"},"modified":"2022-05-02T19:10:02","modified_gmt":"2022-05-02T19:10:02","slug":"antigbm-disease-market-size-in-the-7mm-is-expected-to-rise-by-2030-with-a-cagr-of-222-during-the-study-period-20182030-estimates-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/antigbm-disease-market-size-in-the-7mm-is-expected-to-rise-by-2030-with-a-cagr-of-222-during-the-study-period-20182030-estimates-delveinsight_598238.html","title":{"rendered":"Anti-GBM Disease market size in the 7MM is expected to rise by 2030 with a CAGR of 22.2% during the study period (2018-2030), Estimates DelveInsight"},"content":{"rendered":"
\n
\"Anti-GBM<\/a><\/div>\n
\n
Anti-GBM Disease market<\/div>\n<\/div>\n<\/div>\n

Anti-Glomerular Basement Membrane (anti-GBM) disease (also known as Goodpasture syndrome or disease) is a rare but serious autoimmune disease that causes inflammation in the kidneys and lungs. Anti-GBM disease may affect only the kidneys; however, when it causes both kidney and lung disease, it is called Goodpasture’s syndrome. In anti-GBM disease, the immune system mistakenly makes “anti-GBM antibodies” that attack the lungs and kidneys, leading to bleeding and inflammation in the organs.<\/p>\n

 <\/p>\n

DelveInsight’s ‘Anti-GBM Disease Market Insights, Epidemiology, and Market Forecast 2030’ <\/strong>report delivers an in-depth understanding of the Anti-GBM disease, historical and forecasted epidemiology as well as the Anti-GBM Disease market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.<\/p>\n

 <\/p>\n

Some facts of Anti-GBM Disease Market<\/a> are:<\/strong><\/p>\n